Literature DB >> 2192734

The neuroendocrine approach to psychiatric disorders: a critical appraisal.

E E Müller1.   

Abstract

Tremendous efforts have been made to exploit the strategy of measuring the secretion of hormones into the plasma by the pituitary as a "window to the brain" and therefore as an insight into potential neurotransmitter receptor lesions in patients with psychiatric disorders. This contribution focuses upon the advantages and drawbacks of the neuroendocrine approach, caution and objectiveness necessary for the critical evaluation and interpretations of the data. Factors related to the neurobiology of the medial basal hypothalamus and its peculiar features, the information that can be derived from the administration of a specific neuroregulatory hormone or a neuroactive compound and evaluation of the evoked hormone release, the multiple constraints related to the drug itself and/or the physiology or coexisting pathology of the psychiatric patient under examination, are thoroughly discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2192734     DOI: 10.1007/bf01245441

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  49 in total

1.  Corticotropin-releasing factor and behavior.

Authors:  G F Koob; F E Bloom
Journal:  Fed Proc       Date:  1985-01

Review 2.  Neural control of somatotropic function.

Authors:  E E Müller
Journal:  Physiol Rev       Date:  1987-07       Impact factor: 37.312

3.  Pulsatile intravenous growth hormone (GH) infusion to hypophysectomized rats increases insulin-like growth factor I messenger ribonucleic acid in skeletal tissues more effectively than continuous GH infusion.

Authors:  J Isgaard; L Carlsson; O G Isaksson; J O Jansson
Journal:  Endocrinology       Date:  1988-12       Impact factor: 4.736

Review 4.  Regulation of nigrostriatal and tuberoinfundibular-hypophyseal dopaminergic neurons.

Authors:  K E Moore; S M Wuerthele
Journal:  Prog Neurobiol       Date:  1979       Impact factor: 11.685

Review 5.  Psychoneuroendocrine research in depression. I. Hormone levels of different neuroendocrine axes and the dexamethasone suppression test.

Authors:  R Rupprecht; K P Lesch
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

6.  Differential drug effects on dopamine concentrations and rates of turnover in the median eminence, olfactory tubercle and corpus striatum.

Authors:  G A Gudelsky; E K Moore
Journal:  J Neural Transm       Date:  1976       Impact factor: 3.575

7.  Corticotropin releasing factor (CRF) immunoreactivity in hypothalamic and extrahypothalamic nuclei of sheep brain.

Authors:  M Palkovits; M J Brownstein; W Vale
Journal:  Neuroendocrinology       Date:  1983-10       Impact factor: 4.914

Review 8.  Peptides in the cerebrospinal fluid of neuropsychiatric patients: an approach to central nervous system peptide function.

Authors:  R M Post; P Gold; D R Rubinow; J C Ballenger; W E Bunney; F K Goodwin
Journal:  Life Sci       Date:  1982-07-05       Impact factor: 5.037

9.  Diurnal hypersecretion of growth hormone in depression.

Authors:  J Mendlewicz; P Linkowski; M Kerkhofs; D Desmedt; J Golstein; G Copinschi; E Van Cauter
Journal:  J Clin Endocrinol Metab       Date:  1985-03       Impact factor: 5.958

10.  Stimulation by alpha-adrenergic mechanisms of the secretion of growth hormone-releasing factor (GRF) from perifused rat hypothalamus.

Authors:  Y Kabayama; Y Kato; Y Murakami; H Tanaka; H Imura
Journal:  Endocrinology       Date:  1986-07       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.